杨樱博士拥有国内外医药行业20年的工作经历，横跨业务发展、战略、商业运营、咨询、药物开发和制造。目前她担任赛诺菲大中华区战略与业务发展负责人。在此岗位上，她将致力于推动赛诺菲中国业务发展，并为中国战略的制定及落地做出重要贡献。

在加入赛诺菲之前，她曾就职于复星医药，担任高级副总裁兼首席商务官，负责全球业务和海外业务拓展。在复星之前，她在辉瑞工作了17年，期间担任过不同的角色。她曾领导全球团队制定和执行战略，以推动中长期投资组合、资产组合和组织发展。

杨樱博士拥有复旦大学化学学士学位和美国西北大学工业工程与管理科学博士学位。

Ying has 20 years of pharmaceutical industry experience, immersing in both western and China cultures, and spanning across strategy, business development, business operations, consulting, drug development and manufacturing. She currently leads Sanofi’s Greater China Strategy & Business Development team. In this role, Ying will drive the implementation of the Sanofi China Business Development and be a key contributor to the definition of the China strategy.  

Prior to Sanofi, Ying worked at Fosun Pharmaceuticals as Sr. Vice President, Chief Business and Operations Officer, responsible for global business development and overseas businesses. Before Fosun, she worked in Pfizer for 17 years and served different roles. She was an executive leading global teams and matrix teams to set and execute strategies to drive mid-term to long-term growth, and development of portfolio, assets, and organization.  

Ying holds a Ph.D. in Industrial Engineering & Management Sciences from Northwestern University, and a Bachelor’s degree in Chemistry from Fudan University in Shanghai.